BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10718181)

  • 21. Treatment of giant-cell tumor of the pelvis.
    Sanjay BK; Frassica FJ; Frassica DA; Unni KK; McLeod RA; Sim FH
    J Bone Joint Surg Am; 1993 Oct; 75(10):1466-75. PubMed ID: 8408135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of 54 pelvic osteosarcomas registered by Japanese musculoskeletal oncology group.
    Matsuo T; Sugita T; Sato K; Hotta T; Tsuchiya H; Shimose S; Kubo T; Ochi M
    Oncology; 2005; 68(4-6):375-81. PubMed ID: 16020966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteosarcoma in Manitoba: review of 95 patients.
    Huebert HT
    Can J Surg; 1979 Nov; 22(6):564-8, 572. PubMed ID: 291464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival analysis of elderly patients with osteosarcoma.
    Imura Y; Takenaka S; Kakunaga S; Nakai T; Wakamatsu T; Outani H; Tanaka T; Tamiya H; Oshima K; Hamada K; Naka N; Araki N; Kudawara I; Ueda T; Yoshikawa H
    Int Orthop; 2019 Jul; 43(7):1741-1747. PubMed ID: 31011764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost analysis of three different surgical procedures for treatment of a pelvic tumour.
    Bruns J; Luessenhop S; Behrens P
    Langenbecks Arch Surg; 1998 Oct; 383(5):359-63. PubMed ID: 9860232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for patients with sarcomas of the pelvic bones.
    Kawai A; Healey JH; Boland PJ; Lin PP; Huvos AG; Meyers PA
    Cancer; 1998 Mar; 82(5):851-9. PubMed ID: 9486573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Custom prosthetic reconstruction for proximal tibial osteosarcoma with proximal tibiofibular joint involved.
    Zhang Y; Yang Z; Li X; Chen Y; Zhang S; Du M; Li J
    Surg Oncol; 2008 Aug; 17(2):87-95. PubMed ID: 18160278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone metastases from osteosarcoma.
    San-Julian M; Diaz-de-Rada P; Noain E; Sierrasesumaga L
    Int Orthop; 2003; 27(2):117-20. PubMed ID: 12700938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Iatrogenic tumor metastasis to the pelvis after treatment for hand osteosarcoma. A case report].
    Ebelin M; Missenard G; Nordin JY
    Chir Main; 2000 Nov; 19(5):272-5. PubMed ID: 11147201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.
    Zhang C; Hu J; Zhu K; Cai T; Ma X
    Int Orthop; 2018 Apr; 42(4):927-938. PubMed ID: 29427125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Staging of osteosarcoma with skip metastases].
    Wuisman P; Enneking WF
    Z Orthop Ihre Grenzgeb; 1990; 128(5):457-62. PubMed ID: 2147333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
    Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
    Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-glycoprotein levels predict poor outcome in patients with osteosarcoma.
    Hornicek FJ; Gebhardt MC; Wolfe MW; Kharrazi FD; Takeshita H; Parekh SG; Zurakowski D; Mankin HJ
    Clin Orthop Relat Res; 2000 Apr; (373):11-7. PubMed ID: 10810457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
    J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telangiectatic osteosarcoma: a review of 87 cases.
    Angelini A; Mavrogenis AF; Trovarelli G; Ferrari S; Picci P; Ruggieri P
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2197-207. PubMed ID: 27469493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery.
    Bishop AJ; Livingston JA; Araujo DM; Moon BS; Patel S; Wang WL; Lazar AJ; Roland CL; Guadagnolo BA
    Am J Clin Oncol; 2019 Mar; 42(3):238-242. PubMed ID: 30614820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival data for 648 patients with osteosarcoma treated at one institution.
    Mankin HJ; Hornicek FJ; Rosenberg AE; Harmon DC; Gebhardt MC
    Clin Orthop Relat Res; 2004 Dec; (429):286-91. PubMed ID: 15577500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.